There is a long way to go for the internationalization of traditional Chinese Medicine
-
Last Update: 2014-06-30
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
As the largest export commodity of traditional Chinese medicine, plant extract has maintained a rapid growth for many years, but the growth rate last year was the lowest in nearly 20 years The main reasons are the weak demand of international market and the adjustment of domestic policy In the 114th Canton Fair, exhibitors said that this year, the export of plant extracts has basically come out of last year's downturn, steadily recovered, and the export of many advantageous varieties such as Stevia extract, bilberry extract, licorice extract and so on has recovered a large growth Meanwhile, demand in the US market is rising At present, the main plant extracts exported to the United States are licorice extract, Siraitia grosvenorii extract and extracts for health purposes The United States is the largest export market for plant extracts, with strong demand, indicating a warmer export market for plant extracts The chamber of Commerce for medical insurance pointed out that China's pharmaceutical export has always been dominated by primary processing products such as APIs, medical dressings and traditional Chinese medicine Accelerating the upgrading of the pharmaceutical industry and optimizing the export structure are the only options to change the growth mode of pharmaceutical trade, enhance the international competitiveness of China's pharmaceutical products and return to the high growth of pharmaceutical export In the past two years, China's pharmaceutical export has made a series of breakthroughs Huahai pharmaceutical, Lijian pharmaceutical, Haizheng pharmaceutical, Fosun Pharmaceutical, Xi'an Qianhe pharmaceutical, Dalian Meiluo pharmaceutical, etc are all pioneers in the success of pharmaceutical export In the past, it has been considered that it is difficult to export large infusion products Shijiazhuang No.4 Pharmaceutical Co., Ltd and Sichuan Kelun group have successfully realized export and are expected to enter the U.S market in the near future At present, domestic traditional Chinese medicine enterprises begin to realize that it is the only way to realize the great development of traditional Chinese medicine to go to the world However, in the face of the situation that traditional Chinese medicine with unique advantages is hard to find a place in the world pharmaceutical market, relevant enterprises and departments must actively explore the "modern" internationalization road of traditional Chinese medicine that is understood and accepted by all countries in the world, especially the westerners.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.